Literature DB >> 12560244

Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab.

Kirsten E Herbert, H Miles Prince, David A Westerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12560244     DOI： 10.1182/blood-2002-09-2923

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  The co-existence of pure red cell aplasia and autoimmune haemolytic anaemia in a child with malignant lymphoma.

Authors:  Suhair Abbas Ahmed; Rosline Hassan
Journal:  Malays J Med Sci       Date:  2005-07

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia.

Authors:  C Karlsson; H Dahl; J Lundin; E Rossmann; M Brytting; H Mellstedt; A Linde; A Osterborg
Journal:  Blood Cancer J       Date:  2011-06-10       Impact factor: 11.037

Review 4.  Acquired pure red cell aplasia: updated review of treatment.

Authors:  Kenichi Sawada; Naohito Fujishima; Makoto Hirokawa
Journal:  Br J Haematol       Date:  2008-05-28       Impact factor: 6.998
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.